Advertisement
Advertisement
VRAX
Virax Biolabs Group Ltd - Class A
1.75
USD-0.14
-7.41%
Dec 20, 15:59 UTC -5
Closed
...
Virax Biolabs Group Ltd - Class A Profile
About
Info & Links
CEO
James Foster
Headquarters
Lanarkshire, X0 ML1 5UH, UNITED KINGDOM
Industry
Sector
Website
Auditor
Reliant CPA PC
Share holders
--
Employees
17
Virax Biolabs Group Ltd - Class A Statistics
Valuation Measures
Market Capitalization2
6.30M
Enterprise Value
-763.30K
Enterprise Value/EBITDA(ttm)
--
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
0.60
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
0.00%
Return on Assets(ttm)
--
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
--
Gross Profit(ttm)
0.00
EBITDA(ttm)3
0.00
Net Income Available to Common(ttm)
0.00
Diluted EPS(ttm)
--
Share Statistics
Beta (5Y Monthly)
1.84
52-Week Change
-13.96%
S&P 500 52-Week Change
26.23%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
--
Dividend Yield
0.00%
Float4
1.77M
% Held by Insiders
45.10%
% Held by Institutions
8.61%
Balance Sheet
Total Cash(mrq)
7.29M
Total Cash Per Share(mrq)
--
Total Debt(mrq)
222.70K
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
--
Quick Ratio(mrq)
11.39%
Book Value Per Share(mrq)
--
Cash Flow
Operating Cash Flow Per Share(ytd)
--
Free Cash Flow(ytd)
0.00
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement